Antidepressant adult suicidality committee

Executive Summary

FDA's Psychopharmacologic Drugs Advisory Committee will discuss the results of ongoing FDA meta-analyses of suicidality data from adult antidepressant trials during a Dec. 13 meeting. The panel, along with FDA's Pediatric Advisory Committee, reviewed data concerning the relationship between antidepressants and suicidal thoughts and actions in children and adolescents during two 2004 meetings (1"The Pink Sheet" Sept. 20, 2004, p. 3). The meeting will be held at the Hilton in Silver Spring, Md., beginning at 8 a.m....